← All medicines
Imipenem/Cilastatin 500 mg/500 mg powder for solution for infusion
Licence PA2059/074/002 · Marketed
- Licence holder
- Fresenius Kabi Deutschland GmbH (all products →)
- Active substances
- Imipenem, Cilastatin
- Dosage form
- Powder for solution for infusion
- Route of administration
- Intravenous use
- ATC code
- J01DH51
- First authorised
- 18/12/2020
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.